{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T17:01:18Z","timestamp":1788627678922,"version":"build-2803163510"},"reference-count":42,"publisher":"Wiley","issue":"19","license":[{"start":{"date-parts":[[2009,6,23]],"date-time":"2009-06-23T00:00:00Z","timestamp":1245715200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer"],"published-print":{"date-parts":[[2009,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>BACKGROUND:<\/jats:title><jats:p>The growing numbers of survivors of innovative cancer treatments, such as hematopoietic stem cell transplantation (HSCT), often report subsequent cognitive difficulties. The objective of this study was to evaluate and compare neurocognitive changes in patients with chronic myelogenous leukemia (CML) or primary myelodysplastic syndrome (MDS) after allogeneic HSCT or other therapies.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS:<\/jats:title><jats:p>In this prospective cohort study, serial evaluations of attention, concentration, memory, mood, and quality of life were used in a consecutive sample of 106 eligible patients who had CML (n = 91) or MDS (n = 15) at enrollment and then 12 months and 18 months after HSCT or other therapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS:<\/jats:title><jats:p>The 3 evaluations at enrollment, 12 months, and 18 months were completed by 98%, 95%, and 89% of surviving participants, respectively. Among all patients, there was significant improvement in memory over 18 months. For example, the 45 patients who underwent HSCT (42 patients with CML and 3 patients with MDS) compared favorably with the patients who received other treatment on most measures of neuropsychological function, except they had improved mental health (<jats:italic>P<\/jats:italic> = .034), worse physical function (<jats:italic>P<\/jats:italic> = .049), and more difficulty with coordination and fine motor speed bilaterally (dominant hand, <jats:italic>P<\/jats:italic> = .005; nondominant hand, <jats:italic>P<\/jats:italic> = .0019). Patients with CML overall had improved phonemic fluency (<jats:italic>P<\/jats:italic> = .014).<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS:<\/jats:title><jats:p>The current study indicated that time and diagnosis may be important factors when assessing neurocognitive and other changes. Complaints regarding \u201cchemobrain\u201d after HSCT merit further study, because deficits actually may predate the initiation of treatment and subsequently may improve. The study results could reassure prospective HSCT recipients, because HSCT compared favorably with other treatments when mental status side effects were considered. Cancer 2009. \u00a9 2009 American Cancer Society.<\/jats:p><\/jats:sec>","DOI":"10.1002\/cncr.24496","type":"journal-article","created":{"date-parts":[[2009,6,23]],"date-time":"2009-06-23T14:24:12Z","timestamp":1245767052000},"page":"4625-4635","source":"Crossref","is-referenced-by-count":29,"title":["Mental status changes after hematopoietic stem cell transplantation"],"prefix":"10.1002","volume":"115","author":[{"given":"Grace","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary\u2010Ellen","family":"Meadows","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. John","family":"Orav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph H.","family":"Antin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,6,23]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/bmb\/ldl005"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0463.2005.apm_336.x"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.NCC.0000265002.79687.af"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.12.674"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.189"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2005.01.015"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705108"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22962"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-03-1155"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705663"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1017\/S1355617707070208"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1080\/13803390490918147"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000046522.38465.79"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.5.1457"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1994.12.4.820"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.2466\/pms.1989.68.3c.1227"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2005.09.012"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1080\/07357900701506672"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.4065\/81.7.973"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.4065\/81.1.104"},{"key":"e_1_2_7_22_2","volume-title":"Computing 1989 Prestige Scores. GSS Methodological Report No. 70","author":"Nakao K","year":"1990"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1037\/1040-3590.3.3.412"},{"key":"e_1_2_7_24_2","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00005650-199303000-00006","article-title":"The MOS 36\u2010item, short\u2010form health survey (SF\u201036): psychometric and clinical uses of validity in measuring physical and mental constructs","volume":"331","author":"McHorney CA","year":"1993","journal-title":"Med Care."},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(87)90143-3"},{"key":"e_1_2_7_26_2","volume-title":"Structured Clinical Interview for Axis I DSM\u2010IV Disorders. Patient ed (SCID\u2010I\/P), version 2.0","author":"First MB","year":"1994"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10627"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19921101)70:9<2288::AID-CNCR2820700913>3.0.CO;2-M"},{"key":"e_1_2_7_29_2","volume-title":"A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary","author":"Strauss E","year":"2006"},{"key":"e_1_2_7_30_2","volume-title":"The Mental Status Examination in Neurology","author":"Strub RL","year":"1980"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.24.11.1019"},{"key":"e_1_2_7_32_2","volume-title":"Grooved Pegboard","author":"Psychological Assessment Resources, Inc","year":"2000"},{"key":"e_1_2_7_33_2","volume-title":"Neuropsychological Assessment","author":"Lezak MD","year":"2004"},{"key":"e_1_2_7_34_2","volume-title":"Handbook of Normative Data for Neuropsychological Assessment","author":"Mitrushina M","year":"2005"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1076\/1385-4046(200002)14:1;1-8;FT110"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.2466\/pms.1986.62.2.407"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0887-6177(03)00039-8"},{"key":"e_1_2_7_38_2","first-page":"167","article-title":"Normative data stratified by age and education for 2 measures of verbal fluency: FAS and animal naming","volume":"14","author":"Tombaugh TN","year":"1999","journal-title":"Arch Clin Neuropsychol."},{"key":"e_1_2_7_39_2","volume-title":"SF\u201036 Physical and Mental Health Summary Scales: A Manual for Users of Version 1","author":"Ware JE","year":"2001"},{"key":"e_1_2_7_40_2","first-page":"2062","article-title":"Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft versus host disease after marrow transplantation from unrelated donors","volume":"96","author":"Nash RA","year":"2000","journal-title":"Blood."},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1996.608"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23448"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.2700"}],"container-title":["Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcncr.24496","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncr.24496","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T16:06:06Z","timestamp":1760285166000},"score":1,"resource":{"primary":{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/cncr.24496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,23]]},"references-count":42,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["10.1002\/cncr.24496"],"URL":"https:\/\/doi.org\/10.1002\/cncr.24496","archive":["Portico"],"relation":{},"ISSN":["0008-543X","1097-0142"],"issn-type":[{"value":"0008-543X","type":"print"},{"value":"1097-0142","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,23]]}}}